BusinessFate Therapeutics to Present at the Needham & Company 15th Annual Healthcare ConferenceBy Nasdaq OMXApr 5, 2016, 8:01 PM UTC
BusinessFate Therapeutics Reports Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXMar 3, 2016, 9:01 PM UTC
BusinessFate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2015 Financial Results on March 3, 2016By Nasdaq OMXFeb 25, 2016, 9:01 PM UTC
BusinessFate Therapeutics to Present Preclinical Data for ProTmune™ at 2016 BMT Tandem MeetingsBy Nasdaq OMXFeb 21, 2016, 1:01 PM UTC
BusinessFate Therapeutics Announces FDA Clearance of Investigational New Drug Application for ProTmune for Prevention of Acute GvHD and CMV InfectionBy Nasdaq OMXJan 26, 2016, 9:36 PM UTC
